Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cabergoline 0.25mg Tablets
Therapeutic Category
ENDOCRINOLOGY and Hormonal range, Gynecology and Fertility, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10x1x4
Price
₹249/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cabstyle 0.25 Tablet contains Cabergoline (0.25mg), a dopamine receptor agonist primarily used for managing hormonal imbalances related to high levels of prolactin (hyperprolactinemia). By acting on dopamine receptors in the pituitary gland, it reduces prolactin secretion, restoring hormonal balance and addressing related conditions effectively.
Cabergoline is widely prescribed for the treatment of conditions like prolactinomas, irregular menstrual cycles, and infertility caused by elevated prolactin levels. In addition, it may be used to prevent lactation in specific medical cases. The potent action of Cabergoline ensures effective prolactin regulation, making it a reliable choice for endocrine and reproductive health management.
Cabstyle 0.25 Tablet is manufactured to high standards, ensuring optimal efficacy and minimal side effects. Its convenient dosing and proven safety profile make it suitable for patients under proper medical guidance.
Common side effects include nausea, dizziness, and fatigue. Rarely, it may cause hypotension, depression, or hallucinations.
Treats conditions caused by elevated prolactin, such as infertility, irregular menstruation, and prolactinomas.
Use under medical supervision only. Not recommended during pregnancy unless prescribed by a doctor.
Store in a cool, dry place away from sunlight and moisture. Keep out of reach of children.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cabergoline 0.25mg Tablet has strong demand in the endocrinology and gynecology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on hormonal disorder therapies.
Medical distributors and agencies can benefit from consistent demand for management of hyperprolactinemia (high prolactin levels), prolactinoma, infertility related to hormonal imbalance, and menstrual disorders caused by elevated prolactin. Cabergoline is a dopamine agonist that lowers prolactin levels effectively This strengthens a reliable endocrinology prescription portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cabergoline 0.25mg Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong gynecology and endocrinology prescriptions, chronic hormonal therapy demand, specialist clinic usage, repeat patient cycles, reliable supply chain support, and good margins in niche CNS/endocrine medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.